4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-062241
Chief Executive Officer acquired 252,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2022-12-16 | Grant or award | +18,375 | 3,486,689 | D: show line 1 in the form | ||
| Anzalone Christopher Richard Chief Executive Officer | 2022-12-20 | Grant or award | +234,025 | 3,720,714 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…